Analysts Have Conflicting Sentiments on These Healthcare Companies: Ramsay Health Care (OtherRMSYF), Glass House Brands (OtherGLASF) and RemeGen Co. Ltd. Class H (HK:9995)
UBS Adjusts RemeGen's Price Target to HK$75.20 From HK$75.03, Keeps at Buy
No Data